O'Keeffe Aidan G, Petersen Irene, Nazareth Irwin
Department of Statistical Science, University College London, London, UK.
Department of Primary Care and Population Health, University College London, London, UK.
BMJ Open. 2015 Mar 6;5(3):e007207. doi: 10.1136/bmjopen-2014-007207.
To investigate the extent to which variation exists in the initiation rate of statin therapy for the primary prevention of cardiovascular disease between countries of the UK and between different regions within England.
Cohort study using data from a large UK primary care database.
4,820,885 individuals from 554 general practices during the period 2004-2012.
Rate of statin therapy initiation per 1000 person-years.
Relative to a fixed English rate of 1 initiation per 1000 person-years and accounting for gender, age and social deprivation level, the rate was similar for Scotland at 0.92 (95% CI 0.84 to 1.00) and rates for Northern Ireland and Wales were higher at 1.40 (95% CI 1.20 to 1.62) and 1.18 (95% CI 1.05 to 1.32), respectively. Within England, the regions could be classified into three groups with respect to statin therapy initiation rates (relative to a rate of 1 initiation per 1000 person-years for London): the South Central 0.73 (95% CI 0.64 to 0.83), South West 0.80 (95% CI 0.71 to 0.91), East of England 0.81 (95% CI 0.71 to 0.94) and South East Coast 0.83 (95% CI 0.73 to 0.95); strategic health authorities had similar low rates followed by the East Midlands 0.88 (95% CI 0.73 to 1.05), West Midlands 0.96 (95% CI 0.84 to 1.09), North East 0.96 (95% CI 0.79 to 1.16), Yorkshire and Humber 0.97 (95% CI 0.81 to 1.17) and London strategic health authorities. North West England exhibited the highest rate of statin therapy initiation of 1.16 (95% CI 1.02 to 1.31).
Considerable variation in the rate of statin therapy initiation was observed between the four countries of the UK and between different geographical regions within England.
调查英国不同国家之间以及英格兰不同地区之间,他汀类药物用于心血管疾病一级预防的起始治疗率的差异程度。
采用来自英国一个大型初级医疗数据库的数据进行队列研究。
英国
2004年至2012年期间来自554家全科诊所的4,820,885名个体。
每1000人年的他汀类药物起始治疗率。
相对于英格兰每1000人年1次的固定起始治疗率,并考虑性别、年龄和社会剥夺水平,苏格兰的起始治疗率与之相似,为0.92(95%置信区间0.84至1.00),北爱尔兰和威尔士的起始治疗率较高,分别为1.40(95%置信区间1.20至1.62)和1.18(95%置信区间1.05至1.32)。在英格兰境内,就他汀类药物起始治疗率而言(相对于伦敦每1000人年1次的起始治疗率),各地区可分为三组:中南部为0.73(95%置信区间0.64至0.83),西南部为0.80(95%置信区间0.71至0.91),英格兰东部为0.81(95%置信区间0.71至0.94),东南海岸为0.83(95%置信区间0.73至0.95);战略卫生当局的起始治疗率同样较低,其次是东米德兰兹为0.88(95%置信区间0.73至1.05),西米德兰兹为0.96(95%置信区间0.84至1.09),东北部为0.96(95%置信区间0.79至1.16),约克郡和亨伯赛德为0.97(95%置信区间0.81至1.17)以及伦敦战略卫生当局。英格兰西北部的他汀类药物起始治疗率最高,为1.16(95%置信区间1.02至1.31)。
在英国的四个国家之间以及英格兰不同地理区域之间,观察到他汀类药物起始治疗率存在显著差异。